News | February 10, 2023
Lupin receives approval from USFDA for Glycopyrrolate Injection USP
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
With the recent sales force expansion and new product launches, we expect to be back to above-market growth
Revenue from operations during the quarter was up by 6.7 per cent to Rs 6,407.10 crore against Rs 6,002.2 in the same period last fiscal.
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The company will engage with the agency to resolve the import alert at the earliest.
Medical Tourism will boost India’s economy
USFDA issued issued Form 483 with nine observations, which will be addressed within stipulated time.
There is a great opportunity for utilizing traditional medical practices like Ayurveda in Value Based Healthcare
This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies
The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations
Subscribe To Our Newsletter & Stay Updated
